The positive impact of spontaneous or medically induced hypothyroidism on cancer patient survival [7,8,9,10,86], particularly with the specific withdrawal of T4 in the setting of euthyroid hypothyroxinemia [87], complements extensive in vitro studies of the proliferative action of thyroid hormone on tumor cells. The gene discussed is TG; the disease is neoplasm.